Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

TECX Relative to the S&P 500

TECX Relative to the Sector

Seasonal Chart Analysis

Analysis of the Tectonic Therapeutic, Inc. (NASD:TECX) seasonal charts above shows that a Buy Date of May 10 and a Sell Date of July 29 has resulted in a geometric average return of 18.51% above the benchmark rate of the S&P 500 Total Return Index over the past 6 years. This seasonal timeframe has shown positive results compared to the benchmark in 5 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 6 years by an average of 51.42% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 6 years of data is available for shares of TECX, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.

To download TECX seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: TECX